Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study

By sjmartinez • May 3, 2024

Rastogi A, Pollack CV Jr, Sánchez Lázaro IJ, Lesén E, Arnold M, Franzén S, Allum A, Hernández I, Murohara T, Kanda E. Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study. Clin Kidney J. 2024 Mar 25;17(5):sfae083. doi: 10.1093/ckj/sfae083. PMID: 38699484; PMCID: PMC11062025.

Tags: Chronic kidney disease, heart failure, hyperkalaemia, Nephrology, Publications, renin–angiotensin–aldosterone system inhibitor, sodium zirconium cyclosilicate

C3 glomerulopathy post kidney transplantation: A single center experience

Zuckerman J, Pham PT, Parakkal M, Velazquez AF, Sarkar M, Pablos MA, Bunnapradist S, Lum EL. C3 glomerulopathy post kidney transplantation: A single center experience.[...]

Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Ortiz A, Arreola Guerra JM, Chan JCN, Jha V, Kramer H, Nicholas SB, Pavkov ME, Wanner C, Wong LP, Cheung M, King JM, Grams ME,[...]

Hormones and Nephrons: Disentangling the Thyroid-Kidney Connection

Rhee CM, Narasaki Y. Hormones and Nephrons: Disentangling the Thyroid-Kidney Connection. Clin J Am Soc Nephrol. 2025 Jun 12. doi: 10.2215/CJN.0000000761. Epub ahead of print.[...]